US Stock MarketDetailed Quotes

IMVT Immunovant

Watchlist
  • 27.170
  • -0.580-2.09%
Close Apr 26 16:00 ET
  • 27.170
  • 0.0000.00%
Post 17:27 ET
3.95BMarket Cap-15011P/E (TTM)

Immunovant Key Stats

Immunovant Earnings Date

Currency: USD

Period

Q3 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.36

+26.53%

Strong Buy

Apr 26, 2024

Immunovant Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
Jun 8, 20222022/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
Jun 8, 20222022/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Immunovant Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 26, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg